ub8安卓客户端

<sub id="b1nvf"></sub>
      <thead id="b1nvf"></thead>
      <thead id="b1nvf"></thead>
      <sub id="b1nvf"></sub>

      <sub id="b1nvf"></sub>
      <address id="b1nvf"></address><address id="b1nvf"></address>

      <address id="b1nvf"></address>

      <sub id="b1nvf"></sub>
      <sub id="b1nvf"></sub>

        <sub id="b1nvf"></sub>

          <sub id="b1nvf"></sub><sub id="b1nvf"></sub><sub id="b1nvf"></sub>
          财新传媒
          财新英文 > 要闻 > 正文

          It’s Too Early to Get Excited About Gilead’s New Coronavirus Drug, Experts Say

          2020年02月07日 20:33 来源于 财新网
          Although remdesivir so far appears to be more effective at fighting the deadly virus than other antivirals, the evidence remains light
          Experts say Gilead’s drug remdesivir looks promising, but that it’s far too early to get excited. Photo: IC Photo

          Shares in American biotech company Gilead Sciences Inc. climbed to a more than six-month high this week on news that it had been given the green light to start human trials of an experimental antiviral drug on coronavirus patients in China.

          版面编辑:喻竹杨洋
          财新私房课
          好课推荐
          
          <sub id="b1nvf"></sub>
              <thead id="b1nvf"></thead>
              <thead id="b1nvf"></thead>
              <sub id="b1nvf"></sub>

              <sub id="b1nvf"></sub>
              <address id="b1nvf"></address><address id="b1nvf"></address>

              <address id="b1nvf"></address>

              <sub id="b1nvf"></sub>
              <sub id="b1nvf"></sub>

                <sub id="b1nvf"></sub>

                  <sub id="b1nvf"></sub><sub id="b1nvf"></sub><sub id="b1nvf"></sub>

                  千赢游戏

                  188体育平台

                  泊利彩票登录

                  巨弘首页彩

                  金皇朝2

                  罗马彩票平台-首页

                  7m体育怎么样

                  澳客竞彩|app

                  pt老虎